Pharmacogenomics of osteonecrosis of the jaw.

Abstract

Osteonecrosis of the jaw (ONJ) is a rare but serious drug induced adverse event, mainly associated with the use of antiresorptive medications, such as intravenous (IV) bisphosphonates (BPs) in cancer patients. In this review, we evaluated all the pharmacogenomic association studies for ONJ published up to December 2018. To date, two SNPs (CYP2C8 rs1934951 and RBMS3 rs17024608) were identified to be associated with ONJ by two genome-wide association studies (GWAS). However, all six subsequent candidate gene studies failed to replicate these results. In addition, six discovery candidate gene studies tried to identify the genetic markers in several genes associated with bone remodeling, bone mineral density, or osteoporosis. After evaluating the results of these 6 studies, none of the SNPs was significantly associated with ONJ. Recently, two whole-exome sequencing (WES) analysis (including one from our group) were performed to identify variants associated with ONJ. So far, only our study successfully replicated discovery result indicating SIRT1 SNP rs7896005 to be associated with ONJ. However, this SNP also did not reach genome-wide significance. The major limitations of these studies include lack of replication phases and limited sample sizes. Even though some studies had larger sample sizes, they recruited healthy individuals as controls, not subjects treated with BPs. We conclude that a GWAS with a larger sample size followed by replication phase will be needed to fully investigate the pharmacogenomic markers of ONJ.

• Authors: Guang Yang, Sonal Singh, Yiqing Chen, Issam S Hamadeh, Taimour Langaee, Caitrin W McDonough, L Shannon Holliday, Jatinder K Lamba, Jan S Moreb, Joseph Katz, Yan Gong
• Journal: Bone (Bone) Vol. 124 Pg. 75-82 (07 2019) ISSN: 1873-2763 [Electronic] United States
• PMID: 31022475 (Publication Type: Journal Article, Review)
• Copyright: Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Topics

• Bisphosphonate-Associated Osteonecrosis of the Jaw (drug therapy, genetics)
• Genome-Wide Association Study
• Humans
• Pharmacogenetics
• Reproducibility of Results
• Exome Sequencing